AXGN: Q2 revenue grew 23.1% year-over-year, driven by Breast market acceleration and strong Avance demand
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw 23.1% revenue growth, led by accelerating Breast market adoption and strong Avance demand. Updated guidance calls for at least 24% revenue growth and 73% gross margin for the year, with robust sales force productivity and continued investment in innovation and evidence generation.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw 23.1% revenue growth, led by accelerating Breast market adoption and strong Avance demand. Updated guidance calls for at least 24% revenue growth and 73% gross margin for the year, with robust sales force productivity and continued investment in innovation and evidence generation.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.